Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- FJPWA Working to Ensure Proper Contracts with Medical Institutions
June 28, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
June 28, 2004
- MPC Expanding Product Line in the Field of Cerebrovascular Disease
June 28, 2004
- MEDICAL DEVICE NEWS IN BRIEF
June 28, 2004
- BUSINESS NEWS IN BRIEF
June 28, 2004
- WORLDNEWS IN BRIEF
June 28, 2004
- Annual Business Results
June 28, 2004
- FPMAJ Report Outlines Future Issues in Regard to NHI Drug Pricing
June 28, 2004
- NEW PRODUCTS
June 28, 2004
- Need for New Drug Pricing System Stressed: Korosho Conference
June 28, 2004
- ICH Topics Q8, Q9 Should Reach Step 2 in November
June 28, 2004
- REGULATORY NEWS IN BRIEF
June 28, 2004
- 40,000 May Have Died Due to Medical Malpractice in 2003: Symposium
June 28, 2004
- Nearly 80% of Public Hospitals Posted Deficits in FY2002
June 28, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 28, 2004
- Drug Makers to Be Asked for Pharmacogenomics Research Data: JPMA-ABPI Symposium
June 28, 2004
- Diovan Shows Efficacy Equivalent to Amlodipine in VALUE Study: Novartis
June 28, 2004
- 30% Copayment Rate Affecting Medical Visits: Korosho Survey
June 21, 2004
- NEW PRODUCTS
June 21, 2004
- Members of Patient Groups Show Strong Dissatisfaction with Physicians: OPIR Survey
June 21, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…